BWIN
Baldwin Insurance Group, Inc. Financials Insurance Agents, Brokers & Service Russell 3000
$31.93Close
$16.50 – $32.4952-week range
Nov 3, 2026Next report
Highlights
Strengths
- In a stage-2 uptrend all 8 trend conditions pass
- Leading the market RS 85 · stronger than 85% of stocks over 12 months
- Near its high 2% below its 52-week high
- Tight base near its pivot pullbacks 3% → 1%; 0.3% below its $32.03 pivot
- Volume drying up last 10 days 55% under the 50-day average
Cautions
- Results soon Nov 3, 2026, in 2 days
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
2%
1wk
down 0.1%
price change
1mo
up 0.4%
price change
12-month return
up 49%
market up 11% ·
its own up 31%
F-score
—
— Not assessed
Altman Z″
0.43
Elevated risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
—
price / book
Earnings yield
—
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
up 8%
year on year
EPS growth
—
latest quarter
Sales growth
up 30%
latest quarter · +1 pts
ROE
down 9%
return on equity
Free cash margin
—
D/E
2.67
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Trade setup
ATR%
0.7%
$0.22 a day · 2×ATR $31.49
RS
85 / 99
vs the universe
Trend
8 / 8
trend template
Relative volume
0.5×
vs 50-day average
Up/down volume
0.87
50 sessions
Implied move
—
no option chain · report Nov 3, 2026
Contractions
2
3% → 1%
Pivot
$32.03
0.3% below
Volume dry-up
0.5×
10 vs 50 sessions
Trend template · 8 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
Last reported
Oct 27, 2026
Results reaction
Oct 27, 2026-1% vs market2 sessions after results
Financials
- Net -4%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | — | $567.3M | $980.7M | $1.2B | $1.4B | $1.5B |
| Operating income | -$21.9M | -$31.6M | -$31.1M | -$42.6M | $60.6M | $73.9M |
| Net income | -$15.7M | -$58.1M | -$76.7M | -$164.0M | -$41.1M | -$54.2M |
| Net margin | — | -10% | -8% | -14% | -3% | -4% |
| Earnings per share | -$0.58 | -$1.22 | -$1.35 | -$2.73 | -$0.65 | -$0.80 |
| Cash | $108.5M | $138.3M | $118.1M | $116.2M | $90.0M | $123.7M |
| Long-term debt | $399.0M | — | — | $998.7M | $1.4B | $1.6B |
| Shareholders' equity | $367.8M | $608.4M | $608.1M | $560.4M | $583.2M | $600.2M |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Jul 30, 2026 | Quarterly ↗ | Jun 30, 2026 | 30d |
| May 4, 2026 | Quarterly ↗ | Mar 31, 2026 | 34d |
| Feb 26, 2026 | Annual ↗ | Dec 31, 2025 | 57d |
| Nov 4, 2025 | Quarterly ↗ | Sep 30, 2025 | 35d |
| Aug 5, 2025 | Quarterly ↗ | Jun 30, 2025 | 36d |
| May 6, 2025 | Quarterly ↗ | Mar 31, 2025 | 36d |
| Feb 25, 2025 | Annual ↗ | Dec 31, 2024 | 56d |
| Nov 4, 2024 | Quarterly ↗ | Sep 30, 2024 | 35d |
| Aug 6, 2024 | Quarterly ↗ | Jun 30, 2024 | 37d |
| May 7, 2024 | Quarterly ↗ | Mar 31, 2024 | 37d |
| Feb 28, 2024 | Annual ↗ | Dec 31, 2023 | 59d |
| Nov 7, 2023 | Quarterly ↗ | Sep 30, 2023 | 38d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 27, 2026 | Results · Regulation FD ↗ |
| Oct 9, 2026 | Exhibits only ↗ |
| Sep 21, 2026 | Director or officer change ↗ |
| Sep 14, 2026 | Material agreement · Regulation FD ↗ |
| Jul 30, 2026 | Results ↗ |
| Jun 4, 2026 | Director or officer change · Shareholder vote ↗ |
| May 4, 2026 | Results ↗ |
| Feb 26, 2026 | Results ↗ |
| Jan 2, 2026 | Exhibits only ↗ |
| Jan 2, 2026 | Material agreement · Acquisition or disposal · New obligation · Unregistered share sale · Director or officer change ↗ |
| Dec 2, 2025 | Material agreement · Unregistered share sale · Regulation FD ↗ |
| Nov 4, 2025 | Results ↗ |